Flow-mediated changes in pulse wave velocity: A new clinical measure of endothelial function

European Heart Journal

Volumn 27, Issue 3, 2006, Pages 302-309

  Naka, Katerina K ^a   Tweddel, Ann C ^b   Doshi, Sagar N ^c   Goodfellow, Jonathan ^d   Henderson, Andrew H ^e  

^a UNIVERSITY OF IOANNINA   (Greece)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d PRINCESS OF WALES HOSPITAL   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Atherogenesis; Distensibility; Endothelial function; Flow mediated dilatation; Pulse wave velocity

Indexed keywords

ADULT; ARM; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HEART FAILURE; HUMAN; HYPEREMIA; LEG; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; REDUCTION; SYSTOLIC BLOOD PRESSURE;

ADULT; ARM; ARTERIES; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; HUMANS; LEG; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PUNCTURES; VASODILATION; VASODILATOR AGENTS;

EID: 30744450218     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi619     Document Type: Article

References (33)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 1993;362:801-809.
2. Alexander RW, Dzau VJ. Vascular biology: the past 50 years. Circulation 2000;102: IV112-116.
3. Griffith TM, Edwards DH, Davies RL, Harrison DJ, Evans KT. NO coordinates the behaviour of vascular resistance vessels. Nature (London) 1987;329:442-445.
4. Henderson AH. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol 1997;62:S43-S48.
5. Ramsey MW, Goodfellow J, Jones CJH, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995;92:3212-3219.
6. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001;38:1049-1053.
7. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu Y-E, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis: clinical evaluation of a non-invasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002;22:147-151.
8. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-1596.
9. Katz SD, Schwarz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Circulation 1993;88:55-61.
10. Naka KK, Tweddel AC, Parthimos D, Henderson A, Goodfellow J, Frenneaux MP. Arterial distensibility: acute changes following dynamic exercise in normal subjects. Am J Physiol Heart Circ Physiol 2003;284:H970-H978.
11. Doshi SN, Naka KK, Payne N, Jones CJH, Ashton M, Lewis MJ, Goodfellow, J. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 2001;101:629-635.
12. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
13. Wilson DG, Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Davies S, Wilson JF, Lewis MJ, Stuart AG. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilatation. Circulation 1999;99:909-915.
14. Goodfellow J, Ramsey MW, Luddington LA, Jones CJH, Coates PA, Dunstan F, Lewis MJ, Owens DR, Henderson AH. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ 1996;312:744-745.
15. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-1319.
16. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF, Keyes MJ, Levy D, Vasan RS, Benjamin EJ. Local shear stress and brachial artery flow-mediated dilation. Hypertension 2004;44:134-139.
17. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperaemia of the guinea pig heart. Circ Res 1992;70:208-212.
18. Bank AJ, Kaiser DR, Rajala S, Cheng A. In vivo human brachial artery elastic mechanics: effects of smooth muscle relaxation. Circulation 1999;100:41-47.
19. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-1241.
20. Learoyd BM, Taylor MG. Alterations with age in the viscoelastic properties of human arterial walls. Circ Res 1966;18:278-292.
21. Ting CT, Brin KP, Lin SJ, Wang SP, Chang MS, Chiang BN, Yin FC. Arterial hemodynamics in human hypertension. J Clin Invest 1986;78:1462-1471.
22. Kingwell BA, Medley TL, Waddell TK, Cole TJ, Dart AM, Jennings GL. Large artery stiffness: structural and genetic aspects. Clin Exp Pharmacol Physiol 2001;28:1040-1043.
23. Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrix metalloproteinase-3 contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003;92:1254-1261.
24. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004;24:1479-1484.
25. Yasmin, McEniery CM, Wallace S, Dakham Z, Pusalkar P, Ashby MJ, Cockcroft JR, Wilkinson IB. Matrix metalloproteinase-9 (MMP-9) and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:1-7.
26. Ito A, Egashira K, Kadokami T, Fukumoto Y, Takayanagi T, Nakaike R, Kuga T, Sueshi K, Shimkawa H, Takeshita A. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyper-reactivity to serotonin in pigs. Circulation 1995;92:2636-2644.
27. Fitch RM, Vergona R, Sullivan ME, Wang YX. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 2001;51:351-358.
28. Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K, Kim S, Toba K, Yoshizumi M, Ouchi Y. Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999;19:2795-2800.
29. Wilson AM, O'Neal D, Nelson CL, Prior DL, Best JD, Jenkins AJ. Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens 2004;17:285-291.
30. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33:1111-1117.
31. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM, Blacher J. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439.
32. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-1241.
33. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085-2090.